LF61: a new monoclonal antibody directed against a trimeric molecule (150 kDa, 125 kDa, 105 kDa) associated with hairy cell leukaemia

Summary The newly produced monoclonal antibody (mAb) LF61 detects a molecule restricted to hairy cell leukaemia (HCL) among B‐cell non‐Hodgkin's lymphomas. In particutar, the percentage of LF61+HCL cells in different cases ranges from 10% to 100%. In normal lympho‐haemopoietic tissues LF61 reacts with only about 2% of T‐cells, mostly of the CD8 subset in the peripheral blood. extrafollicular areas of the tonsil, red pulp of the spleen and thymic medulla. Expression of the LF61 molecule is observed following stimulation of peripheral blood lymphocytes with phyto‐haemagglutinin (PHA) or pokeweed mitogen (PWM), suggesting that it represents an activation antigen. Due to its restricted reactivity with a small subset of normal CD8 + T‐cells, LF61 in combination with a CD22 mAb is highly suitable for monitoring residual disease in interferon or deoxycoformicin‐treated HCL patients. Polyacrylamide gel gradient electrophoresis shows that LF61 precipitates a 150 kDa. 125 kDa, 105 kDa trimeric molecule from the surface of HCL cells. Immunohistological and immunobiochemical results show that this molecule is the same as the one recognized by the still unclustered anti‐HCL mAb B‐ly7.

[1]  S. Pileri,et al.  Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon‐treated hairy cell leukaemia patients , 1990, British journal of haematology.

[2]  S. Poppema,et al.  Monoclonal antibodies reactive with hairy cell leukemia. , 1989, Blood.

[3]  M. Ratain,et al.  Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. , 1988, American journal of clinical pathology.

[4]  A. Stansfeld,et al.  UPDATED KIEL CLASSIFICATION , 1988, The Lancet.

[5]  K. Lennert,et al.  Updated Kiel classification for lymphomas , 1989, The Journal of pathology.

[6]  C. Li,et al.  Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience. , 1987, Leukemia.

[7]  H. Stein,et al.  Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells , 1987 .

[8]  B. Falini,et al.  A monoclonal antibody recognizing the p150/95 leucocyte differentiation antigen. , 1986, Immunology.

[9]  H. Stein,et al.  Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases , 1986, Histopathology.

[10]  M. Ratain,et al.  Changes in Peripheral Blood and Bone Marrow Specimens Following Therapy with Recombinant Alpha2 Interferon for Hairy Cell Leukemia , 1986 .

[11]  F. Naeim,et al.  Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon. , 1985, Human pathology.

[12]  C. Worman,et al.  HAIRY‐CELL LEUKAEMIA , 1985, British journal of haematology.

[13]  C. Y. Wang,et al.  The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. , 1985, Blood.

[14]  H. Stein,et al.  The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. , 1985, American journal of clinical pathology.

[15]  D. Fisher,et al.  Hairy cell leukemia: a tumor of pre-plasma cells , 1985 .

[16]  H. Rappaport,et al.  The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen. , 1984, Seminars in oncology.

[17]  T. Waldmann,et al.  Cellular origin of hairy cell leukemia: malignant B cells that express receptors for T cell growth factor. , 1984, Seminars in oncology.

[18]  C. Y. Wang,et al.  An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. , 1984, Journal of immunology.

[19]  H. Kunkel,et al.  A membrane antigen (HC1) selectively present on hairy cell leukemia cells, endothelial cells, and epidermal basal cells. , 1984, Journal of immunology.

[20]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  E. Jaffe,et al.  Hairy cell leukemia: a B cell neoplasm with a unique antigenic phenotype. , 1983, American journal of clinical pathology.

[22]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[23]  H. Kunkel,et al.  Monoclonal antibodies with specificity for hairy cell leukemia cells. , 1982, The Journal of clinical investigation.

[24]  T. Lebien,et al.  The phenotype of the neoplastic cells of hairy cell leukemia studied with monoclonal antibodies , 1982 .

[25]  H. Stein,et al.  Specificities of monoclonal antibodies B-ly7 and HML-1 are identical. , 1990, Blood.

[26]  S. Pileri,et al.  Histological and immunohistological analysis of human lymphomas. , 1989, Critical reviews in oncology/hematology.

[27]  C. Griscelli,et al.  A monoclonal antibody (HML‐1) defining a novel membrane molecule present on human intestinal lymphocytes , 1987, European journal of immunology.

[28]  B. Falini,et al.  A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. , 1986, Immunology.

[29]  D. Fisher,et al.  Hairy cell leukemia: a tumor of pre-plasma cells. , 1985, Blood.

[30]  D. Yuan,et al.  Biosynthetic, surface labeling, and isolation of membrane immunoglobulin. , 1984, Methods in enzymology.

[31]  T. Lebien,et al.  The phenotype of the neoplastic cells of hairy cell leukemia studied with monoclonal antibodies. , 1982, Blood.